DD Specialty Materials · Industrial · Water · Healthcare · Thesis updated August 11, 2026

Building materials recovery strengthens cleaner DuPont

DuPont operates as a more focused company after spinning off Electronics as Qnity in November 2025.
Q2 2026 Healthcare and Water Technologies sales were $856 million, up 5% organically.
Diversified Industrials sales hit $963 million in Q2 2026, marking a return to low single-digit organic growth.
The Building Technologies segment showed early signs of cyclical recovery in Asia Pacific.
Management raised full-year guidance and authorized a new $250 million share repurchase program.

01 Running thesis

Sharper focus meets industrial recovery

DuPont is proving its new structure can work. The company completed its transition to an Industrials classification in July 2026. After spinning off its Electronics business in 2025 and selling the Aramids unit in April 2026, the remaining portfolio is much easier to value.

The bull case is gaining traction. Healthcare and Water Technologies grew Q2 2026 sales organically by 5%. More importantly, the Diversified Industrials segment returned to low single-digit growth. Building materials demand in Asia Pacific is recovering, which suggests the worst of the construction slump might be over.

The bear case still centers on uneven global demand. Middle East logistics disruptions continue to weigh on the water business. Investors also need to see if the building materials recovery will spread to North America, or if it was just a temporary restock in Asia.

Capital return provides a steady floor. The company authorized a new $250 million share repurchase in Q2 2026, adding to earlier buybacks. As management cuts manufacturing complexity, those buybacks help drive earnings growth even if end markets recover slowly.

Aug 2026▲Q2 2026 showed a return to low single-digit growth in Building Technologies and strong 5% organic growth in Healthcare & Water. The company raised full-year guidance and announced a new $250 million buyback.

May 2026▲Q1 2026 showed 3% organic growth in Healthcare & Water Technologies and flat organic sales in Diversified Industrials. DuPont also closed the Aramids sale for about $1.2 billion of cash plus other value and announced plans for a $275 million ASR.

Feb 2026▲The 2025 10-K gave the first clean view of the post-Qnity company. Healthcare & Water Technologies grew 9% in 2025 sales, while Diversified Industrials fell 3%, and DuPont used the Qnity cash distribution to cut debt.

Nov 2025▲DuPont completed the Qnity separation and received about $4.2 billion of cash from the transaction. Management also started the new dividend and a $2 billion share repurchase authorization.

Aug 2025→The pre-spin thesis held steady. Electronics growth stayed strong, IndustrialsCo showed some stabilization, but cash flow was pressured by separation costs and working capital.

May 2025→DuPont reported under its pre-separation ElectronicsCo and IndustrialsCo structure. ElectronicsCo grew strongly, but a $768 million goodwill impairment in IndustrialsCo raised questions about the retained business.

Feb 2025→DuPont changed its separation plan, keeping Water and targeting only the Electronics spin-off by November 2025. The move simplified execution but changed the future profile of the remaining company.

Nov 2024▲Management said it was working to speed up the planned separations and noted improving trends in Water & Protection. Medical packaging demand was expected to normalize in 2025.

02 Business model

Special materials for hard jobs

DuPont makes engineered materials that customers use inside products where failure is costly. That includes medical packaging, biopharma materials, water purification, worker safety, aerospace parts, auto materials, energy applications, and building products.

The company makes money by selling specialized products that often need technical support and customer testing. That can create sticky demand, because customers do not change approved materials quickly in healthcare, water, or aerospace.

The model breaks when end markets slow or customers run down inventory. Construction is a major swing factor, though recent quarters show signs of a rebound. Supply chain trouble can also hurt, as seen with ongoing logistics delays in the Middle East.

After selling non-core units, DuPont used billions in cash to cut debt. The cleaner balance sheet supports a steady stream of dividends and buybacks. Now classified as an industrial company, DuPont must prove it can deliver consistent organic growth.

03 Product portfolio

What DuPont sells now

Growth engine

Healthcare Technologies

This includes materials used in medical packaging and biopharma. Q2 2026 growth was driven by broad-based volume in these areas.

Growth engine

Water Technologies

DuPont sells water purification and separation products, including reverse osmosis membranes. Industrial water demand is strong, though Middle East shipping delays remain a drag.

Steady

Tyvek and safety materials

Tyvek is used in protective gear, packaging, and building wraps. It gives DuPont a well-known product family tied to safety and protection needs.

Steady

Industrial Technologies

This area serves aerospace, automotive, energy, and other industrial uses. Growth in aerospace and EV battery solutions helped lift the segment in Q2 2026.

Cash cow

Building Technologies

DuPont sells materials used in construction and building systems. This segment returned to low single-digit growth in Q2 2026 led by Asia Pacific demand.

04 Business segments

Two businesses after the spin

Healthcare & Water Technologies47%modest

Diversified Industrials53%modest

Segment mix uses Q2 2026 net sales: $856 million for Healthcare & Water Technologies and $963 million for Diversified Industrials.

05 Risk factors

What could go wrong

Construction recovery stalls

Medium impact · Medium odds

Diversified Industrials returned to growth in Q2 2026 on the back of Asian construction demand. If North American building markets stay weak or Asian demand fades, the segment could drag on company growth again.

We watchOrganic sales in Diversified Industrials and management comments on North American Building Technologies orders.

PFAS costs exceed expectations

High impact · Medium odds

DuPont still carries legacy environmental liabilities, including PFAS. Qnity is contractually obligated to cover 44% of certain legacy costs, including obligations tied to the PFAS MOU with Corteva and Chemours. That helps DuPont, but only if Qnity can pay its share.

We watchNew PFAS settlements, changes in reserved liabilities, and Qnity's ability to fund its 44% share.

Supply chain disruption hits water growth

Medium impact · Medium odds

Water Technologies continues to be hurt by logistics disruptions in the Middle East. DuPont depends on global supply chains for materials, shipping, and customer delivery. More conflict or trade disruption could pressure sales and margins.

We watchWater Technologies organic sales, delivery delays, freight costs, and Middle East logistics commentary.

Buybacks mask weak core profit

Low impact · Low odds

DuPont announced another $250 million share repurchase in Q2 2026. Buybacks can lift per-share results, but they do not fix weak end markets. If organic growth stalls, capital return alone may not satisfy investors.

We watchOrganic growth versus share count reduction in each quarterly filing.

Counterparty risk on legacy deals

Medium impact · Low odds

The separation of Qnity left DuPont reliant on its former unit to cover a large portion of shared liabilities. If Qnity faces financial trouble, DuPont could be forced to cover a larger share of the environmental costs.

We watchQnity financial health disclosures and any updates to the Legacy Liabilities Assignment Agreement.

06 Quick answers

In one breath

What does DuPont do after the Qnity spin-off?

DuPont is now a specialty materials company focused on healthcare, water, safety, aerospace, automotive, energy, and building markets. The former Electronics business became Qnity in November 2025.

Why did DuPont change its sector classification?

In July 2026, DuPont's GICS classification changed to Industrials. This recognizes its transformation into a multi-industrial company after separating its electronics and materials businesses.

Is DuPont growing?

Yes, growth is returning. In Q2 2026, Healthcare & Water Technologies grew 5% organically, while Diversified Industrials posted 3% organic growth on early signs of a construction recovery.

What is the biggest DuPont risk?

The biggest risk is a mix of legacy PFAS liabilities and cyclical industrial demand. Qnity must cover 44% of certain legacy costs, but DuPont still depends on Qnity's ability to pay.